Literature DB >> 28802564

Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.

Charlotte D'Mello1, Wagdi Almishri1, Hongqun Liu2, Mark Gordon Swain3.   

Abstract

BACKGROUND & AIMS: Patients with inflammatory liver disease commonly develop debilitating symptoms, called sickness behaviors, which arise via changes in brain function. Monocytes that produce tumor necrosis factor interact with cerebral endothelial cells to activate microglial cells and promote sickness behavior. Platelets regulate inflammation, and aggregates of monocytes and platelets are increased in the circulation of patients with liver disease. We investigated the role of platelets in inducing inflammatory features of circulating monocytes and promoting sickness behaviors in mice with cholestatic liver injury.
METHODS: We performed bile-duct ligations or sham surgeries on C57BL/6 or toll-like receptor 4 (TLR4)-knockout mice to induce liver inflammation. Liver inflammation was also induced in a separate group of mice by administration of concanavalin A. Circulating platelets, aggregates of monocytes and platelets, and activation of microglial cells were measured by flow cytometry. To deplete platelets, mice were given anti-thrombocyte serum or normal rabbit serum (control) 4 days after surgery. Interactions between monocytes and cerebral endothelial cells were analyzed by intravital microscopy. Sickness behaviors were quantified based on time spent by adult mice engaging in social behaviors toward a juvenile mouse, compared with time spent in nonsocial behavior or remaining immobile.
RESULTS: Aggregates of monocytes and platelets in circulation of mice increased significantly following bile-duct ligation. Platelet-monocyte interactions were required for activation of inflammatory monocytes and production of tumor necrosis factor. Platelet depletion greatly reduced adhesive interactions between inflammatory monocytes and adhesive interactions with cerebral endothelial cells and activation of the microglia, as well as development of sickness behavior. Furthermore, TLR4 signaling was important for aggregation of monocytes and platelets, and development of sickness behavior following bile-duct ligation. These findings were confirmed in mice with concanavalin A-induced liver injury.
CONCLUSIONS: In mice with liver inflammation, we found TLR4 and aggregates of monocytes and platelets to regulate microglial activation and development of sickness behavior. These findings might lead to new therapeutic strategies for liver disease-associated symptoms.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fatigue; Liver-to-Brain Communication; Ly6Chigh Monocytes; Monocyte-Cerebral Endothelial Cell Interactions

Mesh:

Substances:

Year:  2017        PMID: 28802564     DOI: 10.1053/j.gastro.2017.08.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

2.  Clinical Significance of PAC-1, CD62P, and Platelet-Leukocyte Aggregates in Acute Ischemic Stroke.

Authors:  Y Zhang; Z Ma; Q Liu; Q Qiao; Q Wu; X Zou; Y Xing; B Zhang
Journal:  Bull Exp Biol Med       Date:  2022-03-29       Impact factor: 0.804

3.  Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging.

Authors:  Jia-Yi Liu; Ye-Yu Cai; Zhu-Yuan Ding; Zi-Yi Zhou; Min Lv; Huan Liu; Li-Yun Zheng; Lan Li; Yong-Heng Luo; En-Hua Xiao
Journal:  J Magn Reson Imaging       Date:  2021-09-21       Impact factor: 5.119

4.  A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.

Authors:  Roosmarijn E Vandenbroucke; Christophe Van Steenkiste; Wouter Claeys; Lien Van Hoecke; Anja Geerts; Hans Van Vlierberghe; Sander Lefere; Griet Van Imschoot; Elien Van Wonterghem; Bart Ghesquière
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 5.  Role of Peripheral Inflammation in Hepatic Encephalopathy.

Authors:  Hassan Azhari; Mark G Swain
Journal:  J Clin Exp Hepatol       Date:  2018-06-25

Review 6.  Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management.

Authors:  Artur Kośnik; Maciej Wójcicki
Journal:  Prz Gastroenterol       Date:  2022-03-18

7.  Effects of Trichophyton mentagrophytes infection on the immune response of rabbits.

Authors:  Chenwen Xiao; Guolian Bao; Qiang Wei; Yan Liu; Jiaoyu Wang; Quanan Ji; Yee Huang
Journal:  PeerJ       Date:  2019-09-20       Impact factor: 2.984

Review 8.  Platelets in chronic liver disease, from bench to bedside.

Authors:  Pierluigi Ramadori; Thomas Klag; Nisar Peter Malek; Mathias Heikenwalder
Journal:  JHEP Rep       Date:  2019-10-25

9.  The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the Mouse.

Authors:  Wagdi Almishri; Rachelle P Davis; Abdel-Aziz Shaheen; Mohammed O Altonsy; Craig N Jenne; Mark G Swain
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

10.  Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.

Authors:  Astrid De Boeck; Bo Young Ahn; Charlotte D'Mello; Xueqing Lun; Shyam V Menon; Mana M Alshehri; Frank Szulzewsky; Yaoqing Shen; Lubaba Khan; Ngoc Ha Dang; Elliott Reichardt; Kimberly-Ann Goring; Jennifer King; Cameron J Grisdale; Natalie Grinshtein; Dolores Hambardzumyan; Karlyne M Reilly; Michael D Blough; J Gregory Cairncross; V Wee Yong; Marco A Marra; Steven J M Jones; David R Kaplan; Kathy D McCoy; Eric C Holland; Pinaki Bose; Jennifer A Chan; Stephen M Robbins; Donna L Senger
Journal:  Nat Commun       Date:  2020-10-05       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.